PDCI Market Access

Canada's Leading Pricing and Reimbursement Consultancy

[PDCI Market Access @PDCImktaccess]

PDCI’s John-Paul Dowson sitting down with Doug Clark at CAHR Market Access 201 today in his first public appearance since becoming CEO of pCPA. #pcpa, #CAHR201, #douglasclark

[PDCI Market Access @PDCImktaccess]

PDCI hopes your holidays will be filled with joy and laughter through the New Year. Our offices will be closed on December 26 and 27, and January 2 (and 3 in QC) to observe statutory holidays. We will also close at noon on 23 and 30. We look forward to working with you in 2023!

[PDCI Market Access @PDCImktaccess]

This commentary by W. Neil Palmer argues that the PMPRB has demonstrated little to no interest in patient health or health outcomes.

https://t.co/SYHzHxxPf6

[PDCI Market Access @PDCImktaccess]

PDCI new study finds Canada ranks 10th out of 14 countries on its attractiveness for new medicine launch. This extensive research serves to make this case and why policy makers must make the right decision to keep Canada ahead of the rest of the world. https://t.co/rFbwzqdH7M

[@CanadaforRare @canadaforrare]

Save Rare Lives! Canada needs a national plan for rare diseases and the Canadian Organization for Rare Disorders (CORD) is calling all Canadians to send governments a message: It's time to act. Learn more: https://t.co/ZY0gDuga2o #SaveRareLives #Canada4Rare #Support

[PDCI Market Access @PDCImktaccess]

Canadian Cancer Society, in partnership with PDCI, has published a new report: uncovers the hidden costs of take-home cancer drugs in Ontario and the urgent need for provincial funding https://t.co/PtokVZbOlc via @cancersociety

[PDCI Market Access @PDCImktaccess]

From all of us at PDCI Market Access, we wish you and your families a wonderful holiday season! We look forward to working with you in 2022! We will be closed on December 27 and 28, and January 3 to observe statutory holidays. We will also close at noon on December 24 and 31.

[PDCI Market Access @PDCImktaccess]

Read our whitepaper on Uncovering the Hidden Costs of Take-Home Cancer Drugs (THCD)
https://t.co/azWD2Q9Ixz

#pdicmarketaccess #takehomecancerdrugs #marketaccess

[PDCI Market Access @PDCImktaccess]

We are excited to announce that we have two new additions to the PDCI Market Access team.

https://t.co/YIuQsXJugQ

[PDCI Market Access @PDCImktaccess]

PDCI Market Access is now hiring the following position:
- Pricing Data Research Assistant
Read more: https://t.co/AQQHHL6ken

[PDCI Market Access @PDCImktaccess]

We are excited to announce John Anacleto joining the PDCI Market Access team.

[PDCI Market Access @PDCImktaccess]

@PDCImktaccess is excited to announce that we have two new additions to the PDCI Market Access team!

Jessica Birrell joins PDCI as Manager, Market Access. and Rachel Arcand joins PDCI as Analyst, Market Access/Analyste, Accès au marché.
https://t.co/jOmNlX1sVg

[PDCI Market Access @PDCImktaccess]

The #PMPRB Patented Medicines Regulations have been delayed until January 1, 2022.

https://t.co/O9lOGGzVBQ

#pricing #cdnpoli #pharma

[PMPRB_CEPMB @PMPRB_CEPMB]

#PMPRB webinar for patentees on Online Filing Tool & Transition Measures for Grandfathered & Gap Medicines is taking place June 15 from 1:30 – 3:30 pm EDT. Registration: https://t.co/a5srz501NK #cdnhealth #drugprices

[PDCI Market Access @PDCImktaccess]

Register for the webinar here: https://t.co/XDUM9EKsb9

[PDCI Market Access @PDCImktaccess]

@PDCImktaccess is now hiring the following positions:

Market Access Associate
Market Access Analyst
Manager, Data Innovation and Insights
Pricing Data Research Assistant
Director, Private Payer & Data Innovation
Manager, Market Access & Project Manager

https://t.co/w4idMU0GeR

[PDCI Market Access @PDCImktaccess]

See our career opportunities here: https://t.co/XHH5YI8BTD

#hiring #pharma #marketaccess #cdnhealth

[PDCI Market Access @PDCImktaccess]

The PMPRB has announced that the maximum list price (MLP) compliance timeline for Grandfathered and Gap Medicines is 2 PMPRB reporting periods, rather than their amended 1 reporting period timeline.

#pharma #healthpolicy #cdnpharma #drugpricing #marketaccess #news

[PDCI Market Access @PDCImktaccess]

NACI has developed a draft process for determining when and how they should incorporate economic evidence into recommendations: https://t.co/Eq2sZpUkS0

Read @PDCImktaccess 's Target Pharma release here: https://t.co/DCP5hAHSVU

#healthecon #cdnpoli #marketaccess #pharma